NO20000301L - Termodynamisk stabil modifikasjon av 1-(4-karbazolyloksy)-3- [2-(2-metoksyfenoksy)etylamino]-2-propanol, fremgangsmåte for fremstilling derav og farmasøytiske blandinger som inneholder den - Google Patents
Termodynamisk stabil modifikasjon av 1-(4-karbazolyloksy)-3- [2-(2-metoksyfenoksy)etylamino]-2-propanol, fremgangsmåte for fremstilling derav og farmasøytiske blandinger som inneholder denInfo
- Publication number
- NO20000301L NO20000301L NO20000301A NO20000301A NO20000301L NO 20000301 L NO20000301 L NO 20000301L NO 20000301 A NO20000301 A NO 20000301A NO 20000301 A NO20000301 A NO 20000301A NO 20000301 L NO20000301 L NO 20000301L
- Authority
- NO
- Norway
- Prior art keywords
- carbazolyloxy
- methoxyphenoxy
- ethylamino
- propanol
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97112491A EP0893440A1 (en) | 1997-07-22 | 1997-07-22 | Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it |
PCT/EP1998/004475 WO1999005105A1 (en) | 1997-07-22 | 1998-07-18 | Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20000301D0 NO20000301D0 (no) | 2000-01-21 |
NO20000301L true NO20000301L (no) | 2000-01-21 |
NO313588B1 NO313588B1 (no) | 2002-10-28 |
Family
ID=8227094
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20000301A NO313588B1 (no) | 1997-07-22 | 2000-01-21 | Termodynamisk stabil modifikasjon av 1-(4-karbazolyloksy)-3- [2-(2-metoksyfenoksy)etylamino]-2-propanol, fremgangsmåte forfremstilling derav og farmasöytiske blandinger som inneholder den |
Country Status (32)
Country | Link |
---|---|
EP (2) | EP0893440A1 (no) |
JP (1) | JP2001510824A (no) |
KR (1) | KR100336229B1 (no) |
CN (1) | CN1125047C (no) |
AR (1) | AR015133A1 (no) |
AT (1) | ATE236123T1 (no) |
AU (1) | AU740453B2 (no) |
BR (1) | BR9810776A (no) |
CA (1) | CA2296637C (no) |
CZ (1) | CZ296947B6 (no) |
DE (1) | DE69812964T2 (no) |
DK (1) | DK1000027T3 (no) |
ES (1) | ES2195366T3 (no) |
HK (1) | HK1029339A1 (no) |
HR (1) | HRP980406A2 (no) |
HU (1) | HUP0003198A3 (no) |
IL (1) | IL133677A (no) |
MA (1) | MA26523A1 (no) |
MY (1) | MY117734A (no) |
NO (1) | NO313588B1 (no) |
NZ (1) | NZ502136A (no) |
PE (1) | PE96999A1 (no) |
PL (1) | PL191602B1 (no) |
PT (1) | PT1000027E (no) |
RU (1) | RU2202542C2 (no) |
SI (1) | SI1000027T1 (no) |
TR (1) | TR200000148T2 (no) |
TW (1) | TW505631B (no) |
UY (1) | UY25108A1 (no) |
WO (1) | WO1999005105A1 (no) |
YU (1) | YU2200A (no) |
ZA (1) | ZA986475B (no) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2402336C (en) * | 2000-04-03 | 2008-03-11 | F. Hoffmann-La Roche Ag | Concentrated solutions of carvedilol |
EP1655285A1 (en) * | 2000-06-28 | 2006-05-10 | Teva Pharmaceutical Industries Ltd. | Method for preparation of a crystalline form of carvedilol (form II) |
CN1245974C (zh) * | 2000-06-28 | 2006-03-22 | 特瓦制药工业有限公司 | 卡维地洛 |
AU2002326391A1 (en) * | 2001-07-13 | 2003-01-29 | Smithkline Beecham Corporation | Carvedilol polymorph |
WO2003024426A1 (en) | 2001-09-21 | 2003-03-27 | Egalet A/S | Controlled release solid dispersions |
CN1308307C (zh) * | 2001-09-28 | 2007-04-04 | 弗·哈夫曼-拉罗切有限公司 | 假多晶型的卡维地洛 |
MXPA04006909A (es) | 2002-01-15 | 2005-04-19 | Teva Pharma | Solidos cristalinos de carvedilol y procesos para su preparacion. |
US20050148779A1 (en) * | 2002-04-30 | 2005-07-07 | Wei Chen | Carvedilol monocitrate monohydrate |
CA2492084A1 (en) | 2002-06-27 | 2004-01-08 | Sb Pharmco Puerto Rico Inc. | Carvedilol hydobromide |
CN1678305A (zh) | 2002-06-27 | 2005-10-05 | Sb药物波多黎各公司 | 卡维地洛磷酸盐和/或其溶剂合物和/或相应组合物和/或治疗方法 |
WO2004041252A1 (en) * | 2002-11-08 | 2004-05-21 | Egalet A/S | Controlled release carvedilol compositions |
WO2004084868A1 (en) | 2003-03-26 | 2004-10-07 | Egalet A/S | Morphine controlled release system |
EP1615888A1 (en) * | 2003-04-21 | 2006-01-18 | Matrix Laboratories Ltd | Process for the preparation of carvedilol form-ii |
SI21616A (sl) * | 2003-09-02 | 2005-04-30 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Nove kristalne oblike karvedilola |
WO2005051383A1 (en) * | 2003-11-25 | 2005-06-09 | Sb Pharmco Puerto Rico Inc. | Carvedilol salts, corresponding compositions, methods of delivery and/or treatment |
DK1838670T3 (da) * | 2004-12-09 | 2010-03-01 | Zach System Spa | Fremgangsmåde til fremstilling af carvedilol og dets enantiomere |
US20070043099A1 (en) * | 2005-06-09 | 2007-02-22 | Igor Lifshitz | Crystalline forms of carvedilol and processes for their preparation |
WO2008002683A2 (en) | 2006-06-28 | 2008-01-03 | Teva Pharmaceutical Industries Ltd. | Polymorphous forms of carvedilol phosphate |
US20080249317A1 (en) * | 2007-04-04 | 2008-10-09 | Apotex Inc. | Novel amorphous form of carvedilol phosphate and processes for the preparation thereof |
CA2687192C (en) | 2007-06-04 | 2015-11-24 | Egalet A/S | Controlled release pharmaceutical compositions for prolonged effect |
CA2751667C (en) | 2009-02-06 | 2016-12-13 | Egalet Ltd. | Immediate release composition resistant to abuse by intake of alcohol |
NZ597283A (en) | 2009-06-24 | 2013-07-26 | Egalet Ltd | Controlled release formulations |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2815926A1 (de) * | 1978-04-13 | 1979-10-18 | Boehringer Mannheim Gmbh | Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
DE3319027A1 (de) * | 1983-05-26 | 1984-11-29 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur herstellung von optisch aktiven carbazol-derivaten, neue r- und s-carbazol-derivate, sowie arzneimittel, die diese verbindungen enthalten |
-
1997
- 1997-07-22 EP EP97112491A patent/EP0893440A1/en not_active Withdrawn
-
1998
- 1998-07-15 PE PE1998000626A patent/PE96999A1/es not_active Application Discontinuation
- 1998-07-15 MY MYPI98003245A patent/MY117734A/en unknown
- 1998-07-18 IL IL13367798A patent/IL133677A/en not_active IP Right Cessation
- 1998-07-18 WO PCT/EP1998/004475 patent/WO1999005105A1/en active IP Right Grant
- 1998-07-18 CZ CZ20000221A patent/CZ296947B6/cs not_active IP Right Cessation
- 1998-07-18 JP JP2000504104A patent/JP2001510824A/ja active Pending
- 1998-07-18 DK DK98937576T patent/DK1000027T3/da active
- 1998-07-18 NZ NZ502136A patent/NZ502136A/en unknown
- 1998-07-18 EP EP98937576A patent/EP1000027B1/en not_active Expired - Lifetime
- 1998-07-18 AU AU86319/98A patent/AU740453B2/en not_active Ceased
- 1998-07-18 CN CN98807436A patent/CN1125047C/zh not_active Expired - Fee Related
- 1998-07-18 RU RU2000103033/04A patent/RU2202542C2/ru not_active IP Right Cessation
- 1998-07-18 AT AT98937576T patent/ATE236123T1/de not_active IP Right Cessation
- 1998-07-18 TR TR2000/00148T patent/TR200000148T2/xx unknown
- 1998-07-18 HU HU0003198A patent/HUP0003198A3/hu unknown
- 1998-07-18 PT PT98937576T patent/PT1000027E/pt unknown
- 1998-07-18 DE DE69812964T patent/DE69812964T2/de not_active Expired - Fee Related
- 1998-07-18 YU YU2200A patent/YU2200A/sh unknown
- 1998-07-18 SI SI9830442T patent/SI1000027T1/xx unknown
- 1998-07-18 BR BR9810776-3A patent/BR9810776A/pt not_active Application Discontinuation
- 1998-07-18 CA CA002296637A patent/CA2296637C/en not_active Expired - Fee Related
- 1998-07-18 TW TW087111738A patent/TW505631B/zh not_active IP Right Cessation
- 1998-07-18 ES ES98937576T patent/ES2195366T3/es not_active Expired - Lifetime
- 1998-07-18 KR KR1020007000667A patent/KR100336229B1/ko not_active IP Right Cessation
- 1998-07-18 PL PL338432A patent/PL191602B1/pl unknown
- 1998-07-20 MA MA25178A patent/MA26523A1/fr unknown
- 1998-07-21 AR ARP980103547A patent/AR015133A1/es unknown
- 1998-07-21 ZA ZA9806475A patent/ZA986475B/xx unknown
- 1998-07-22 UY UY25108A patent/UY25108A1/es not_active IP Right Cessation
- 1998-07-22 HR HR97112491.2A patent/HRP980406A2/hr not_active Application Discontinuation
-
2000
- 2000-01-21 NO NO20000301A patent/NO313588B1/no unknown
-
2001
- 2001-01-02 HK HK01100012A patent/HK1029339A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20000301D0 (no) | Termodynamisk stabil modifikasjon av 1-(4-karbazolyloksy)-3- [2-(2-metoksyfenoksy)etylamino]-2-propanol, fremgangsmåte for fremstilling derav og farmasoeytiske blandinger som inneholder den | |
DK1202965T3 (da) | Indolderivater, fremgangsmåde til fremstilling deraf, farmaceutiske præparater indeholdende disse og deres medicinske anvendelse | |
HUP0203257A3 (en) | Polymorphic forms of atorvastatin calcium, process for their preparations and pharmaceutical compositions containing them | |
EE200000707A (et) | Oksasolidinooni derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid | |
HUP9701694A3 (en) | Indolinone derivatives for the treatment of disease, use thereof, pharmaceutical compositions containing these compounds | |
EE04779B1 (et) | 1,3-dihüdro-2H-indool-2-ooni derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid | |
CO5160257A1 (es) | La n-piperidino-5-(4-bromofenil)-1-(2,4-diclorofenil)-4-etilpirazol-3-carboxamida, sus sales, su preparacion y las composiciones farmaceuticas que la contienen | |
IS1850B (is) | Kristölluð a-fjölgervingsmynd af indól afleiðu, notkun hennar, aðferð til framleiðslu og lyfjaefnablanda | |
NO20015309L (no) | 1- (P-tienylbenzyl)-imidazoler som anginotensin-(1-7) reseptoragonister, fremgangsmåte for fremstilling og anvendelse avde samme og farmasöytiske preparater som inneholder nevnteforbindelser | |
NO20005430L (no) | 1-[(1-substituerte-4-piperidinyl)metyl]-4-piperidinderivater, fremgangsmåter for fremstilling av disse, medisinske preparater inneholdende disse, og mellomprodukter for disse forbindelser | |
NO20024891L (no) | Farmasöytiske sammensetninger | |
HUP0203873A3 (en) | Substituted indole mannich bases, process for their preparation and pharmaceutical compositions containing them | |
NO984290L (no) | Farmas°ytisk nyttige forbindelser | |
HK1027563A1 (en) | Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same. | |
HUP0401499A3 (en) | Indole derivatives as cox ii inhibitors, process for their preparation and pharmaceutical compositions containing them | |
PL370412A1 (en) | Pseudopolymorphic forms of carvedilol | |
HUP0201338A2 (en) | Novel indole derivatives, pharmaceutical compositions containing them and their use | |
ZA200303113B (en) | Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them. | |
AU2002346457A1 (en) | Pharmaceutical formulations comprising indolinone derivatives | |
EE04778B1 (et) | Hargnenud ahelaga asendatud 3-amino-1-fenüül-1H-[1,2,4]triasooli aminoderivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid | |
DK1037613T3 (da) | Fremgangsmåde til fremstilling af farmaceutiske formuleringer, der indeholder en ekstrakt | |
EE04437B1 (et) | (1-fenatsüül-3-fenüül-3-piperidinüületüül)piperidiini derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid | |
EE200100499A (et) | Uued morfoliini derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid | |
HUP0004432A3 (en) | Thermodynamically stable form of (r)-3-[[(4-fluorophenyl)sulphonyl]amino]-1,2,3,4-tetrahydro-9h-carbazole-9-propanoic acid (ramatroban) and pharmaceutical composition containing it | |
NO20005158L (no) | FremgangsmÕte for fremstilling av R-(+)-6-karboksamido-3-N- metylamino-1,2,3,4-tetrahydrokarbazol |